(NASDAQ:SRZN), SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will present at two upcoming healthcare investor conferences. 37th Annual Piper Sandler […]

(NASDAQ:ALGM), MANCHESTER, N.H., Nov. 25, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the company will present at the 53rd Annual Nasdaq Investor Conference held in Association with Morgan Stanley on Wednesday, December 10,

CashUSA Personal Loan Marketplace Releases 2025 Holiday Season Guide: Eligibility, Funding Timelines, and Financial Alternatives In-Depth Consumer Resource Examines Personal Loan Requirements, Credit Check Processes, APR Rate Factors, Next-Day Funding Timelines, Tribal Lender Considerations, Debt Consolidation Strategies, and Borrower Protection Rights During 2025 Holiday Budget Season GlobeNewswire November 25, 2025 Atlanta, Nov. 25, 2025 (GLOBE

Safehold Inc. (the “Company” or “Safehold”) (NYSE: SAFE) today announced that it has closed on a $400 million unsecured term loan. The new term loan has a fully extended maturity date of November 15, 2030 which includes two twelve-month extension options. Pursuant to the terms of the loan, Safehold's current A3 / A- / A-

Alpha Metallurgical Resources, Inc. (NYSE: AMR), a leading U.S. supplier of metallurgical products for the steel industry, today announced its 2026 domestic sales commitments. https://mma.prnewswire.com/media/1429917/Alpha_Metallurgical_Resources_Logo.jpg Alpha has committed approximately 3.6 million tons of metallurgical coal to domestic customers at an average price of $136.75 per ton. “With negotiations now complete, we are pleased to have

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, todayannounced that it will participate at the Piper Sandler 37th Annual Healthcare Conference. The conference will take place December 2-4, 2025, in New York, New York. https://mma.prnewswire.com/media/273590/viking_9_15_logo.jpg Details are as follows: — Piper

Solventum(NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00 a.m. EST in New York, NY. https://mma.prnewswire.com/media/2369614/Solventum_Logo.jpg A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About SolventumAt Solventum,

Giga Metals Announces Positive Geophysical Results GlobeNewswire November 25, 2025 VANCOUVER, British Columbia, Nov. 25, 2025 (GLOBE NEWSWIRE) — Scott Lendrum, CEO of Giga Metals Corp. (TSX-V: GIGA; OTCQB: GIGGF; FSE: BRR2) today announced receipt of results from the recent Magnetotelluric (MT) geophysical survey at Turnagain, interpreted by Matthew Penney, President of Hardrock Geophysics. Highlights:

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference GlobeNewswire November 25, 2025 ROCKVILLE, MD, Nov. 25, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside

Nukkleus Inc. Announces Date of the Special Meeting of Stockholders to Approve Acquisition of Star 26 Capital, Inc. GlobeNewswire November 25, 2025 NEW YORK and TEL AVIV, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense